A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROL

Project: Research project

Project Details

Description

A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSEESCALATION STUDY OF THE SAFETY, TOLERABILITY AND ABILITY OF CMX001 TO PREVENT OR CONTROL CMV INFECTION IN R+ HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
StatusFinished
Effective start/end date11/17/099/29/12

Funding

  • Chimerix, Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.